Status: Recruiting
Prediction of LVAR and MACE in STEMI Though Plasma Multiomics Analysis
To identify plasma multi-omics biomarkers that predict left ventricular adverse remodeling (LVAR) and major adverse cardiovascular events (MACE) in patients with acute ST-segment elevation myocardial infarction, and to investigate the molecular pathways linked to LVAR and MACE.
Participants needed: 1,000
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: Beijing Anzhen HospitalUpdated: May 12, 2026Locations: 1
Eligibility criteria
Age ≥18 years and ≤80 years. [+6]
Non-atherosclerotic MI: coronary embolism, spasm, aortic dissection, myocarditis... [+14]